THE EFFECT OF EVOLOCUMAB ALONE AND IN COMBINATION WITH ATORVASTATIN ON LIPID PROFILE.

Saud, Ali H; Ali, Nabeel A J; Gali, Fadhil Y; Hadi, Najah R

Saud, Ali H; Ali, Nabeel A J; Gali, Fadhil Y; Hadi, Najah R.

Afiliación

Saud AH; DEPARTMENT OF PHARMACOLOGY AND THERAPEUTICS, COLLEGE OF MEDICINE, UNIVERSITY OF KUFA, NAJAF, IRAQ.
Ali NAJ; DEPARTMENT OF PHARMACOLOGY, COLLEGE OF MEDICINE, UNIVERSITY OF BASRA, BASRA, IRAQ.
Gali FY; DEPARTMENT OF PHARMACOLOGY AND THERAPEUTICS, COLLEGE OF MEDICINE, UNIVERSITY OF KUFA, NAJAF, IRAQ.
Hadi NR; DEPARTMENT OF PHARMACOLOGY AND THERAPEUTICS, COLLEGE OF MEDICINE, UNIVERSITY OF KUFA, NAJAF, IRAQ.

Wiad Lek ; 74(12): 3184-3187, 2021.

Article en En | MEDLINE | ID: mdl-35058387

Asunto(s)

Anticolesterolemiantes; Animales; Anticuerpos Monoclonales Humanizados; Atorvastatina; LDL-Colesterol; Lípidos; Masculino; Conejos

Palabras clave

HMG-COA reductase inhibitors; atorvastatin; cardiovascular diseases; evolocumab; hypercholesterolemia

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticolesterolemiantes Límite: Animals Idioma: En Revista: Wiad Lek Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Irak Pais de publicación: Polonia

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links